INS and type 2 diabetes mellitus: Chitosan oligosaccharide was used as a supplementary drug for improving the glycemic control of sitagliptin in type 2 diabetes mellitus (T2DM) by reducing insulin resistance and proinflammatory cytokines, and increasing insulin sensitivity [150].